MDxHealth Reports Preliminary Q2 and Half Year 2024 Revenues and Raises 2024 Revenue Guidance The Company's cash balance as of June 30, 2024, was $21.3 million. About mdxhealth® The preliminary unaudited financial data for the second quarter and six-month period ended June 30, 2024, and the updated 2024 revenue guidance set forth above were derived from preliminary internal financial reports. The Company has not yet finalized its complete results of operations for the period ended June 30, 2024. The Company ...

The Company's cash balance as of June 30, 2024, was $21.3 million. About mdxhealth® The preliminary unaudited financial data for the second quarter and six-month period ended June 30, 2024, and the updated 2024 revenue guidance set forth above were derived from preliminary internal financial reports. The Company has not yet finalized its complete results of operations for the period ended June 30, 2024. The Company and its auditors may identify items that would require the Company to make adjustments, some ...

MDxHealth SA (NASDAQ:MDXH) Q1 2024 Results Conference Call May 1, 2024 8:30 AM ET Company Participants Michael McGarrity - CEO Ron Kalfus - CFO Conference Call Participants Andrew Brackmann - William Blair Jason Bednar - Piper Sandler Mark Massaro - BTIG Daniel Brennan - TD Cowen Thomas Vranken - KBC Operator Good morning, ladies and gentlemen, and welcome to the MDxHealth First Quarter 2024 Earnings Call. At this time, all lines are in a listen-only mode. Following the presentation, we will conduct a quest ...

Exhibit 4.1 CREDIT AGREEMENT dated as of May 1, 2024 by and among MDXHEALTH, INC., as the Borrower, MDXHEALTH SA, as Parent, ORC SPV LLC, as the Initial Lender, and ORC SPV LLC, as the Administrative Agent TABLE OF CONTENTS | | | Page | | --- | --- | --- | | Article I | DEFINITIONS AND ACCOUNTING TERMS | 1 | | SECTION 1.1 | Defined Terms. | 1 | | SECTION 1.2 | Use of Defined Terms | 24 | | SECTION 1.3 | Cross-References | 24 | | SECTION 1.4 | Accounting and Financial Determinations | 24 | | Article II | COM ...

MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMed Year-over-year Q1 revenues increase by 35% to $19.8 millionIncreasing 2024 revenue guidance to $83-85 million, previously $79-81 million Conference call with Q&A today at 08:30 AM ET / 14:30 CET IRVINE, CA, and HERSTAL, BELGIUM – May 1, 2024 (GlobeNewswire) – MDxHealth SA (NASDAQ:MDXH) (the "Company" or "mdxhealth"), a commercial-stage precision diagnostics company, today announced its financial results for the first quarter ended ...

FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 19 ...

MDxHealth SA (NASDAQ:MDXH) Q4 2023 Earnings Conference Call March 6, 2024 4:30 PM ET Company Participants Michael McGarrity - CEO Ron Kalfus - CFO Conference Call Participants Andrew Brackmann - William Blair Thomas Vranken - KBC Securities Jason Bednar - Piper Sandler Mark Massaro - BTIG Operator Good afternoon, ladies and gentlemen and welcome to the MDxHealth Fourth Quarter and Full Year 2023 Earnings Conference Call. At this time, all lines are in a listen-only mode. Following the presentation, we will ...

Company Participants Conference Call Participants Operator At this time, all lines are in a listen-only mode. Following the presentation, we will conduct a question and answer session. [Operator Instructions] Also note that this call is being recorded on Wednesday, November 8, 2023. Michael McGarrity Third quarter results demonstrate our continued execution and commitment to deliver strong and sustainable growth for all of our stakeholders by focusing on commercial execution and operating discipline. As the ...

Michael McGarrity - Chief Executive Officer Ron Kalfus - Chief Financial Officer Operator Michael McGarrity Company Participants Dan Brennan - TD Cowen Andrew Brackmann - William Blair Jason Bednar - Piper Sandler Thomas Vranken - KBC Securities Francois Brisebois - Oppenheimer & Co Before we begin, I would like to remind everyone that we will make forward-looking statements during today's call. Whether in prepared remarks or during the Q&A session, these forward-looking statements are subject to inherent r ...

MDxHealth SA (MXDHF) Q1 2023 Earnings Conference Call May 15, 2023 4:30 AM ET Company Participants Michael McGarrity - Chief Executive Officer Ron Kalfus - Chief Financial Officer Conference Call Participants Andrew Brackmann - William Blair Thomas Vranken - KBC Securities Mark Massaro - BTIG Operator Greetings. Welcome to the MDxHealth First Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Inst ...